Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Veru Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
VERU
Nasdaq
2830
verupharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Veru Inc.
Veru And 2 Other Intriguing Penny Stocks To Watch
- Jun 5th, 2026 6:05 am
Novo Nordisk Tests Wegovy Combinations In Older Adults With Veru Trial
- Jun 5th, 2026 12:09 am
This Small-Cap Biotech Just Soared Over 160% — What Is The Novo Nordisk Connection?
- Jun 4th, 2026 11:16 am
Veru Teams Up With Novo Nordisk for Obesity Combination Therapy Trial (VERU)
- Jun 4th, 2026 8:22 am
Earnings call transcript: Veru Inc Q2 2026 shows improved financials
- May 31st, 2026 10:11 pm
Veru Inc (VERU) Q2 2026 Earnings Call Highlights: Promising Clinical Trial Results Amid ...
- May 13th, 2026 5:03 pm
Transcript: Veru Q2 2026 Earnings Conference Call
- May 13th, 2026 6:50 am
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
- May 13th, 2026 4:30 am
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
- May 6th, 2026 6:30 am
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
- Mar 9th, 2026 6:30 am
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Feb 19th, 2026 6:30 am
Veru Inc (VERU) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
- Feb 11th, 2026 12:01 pm
Veru Inc. Q1 2026 Earnings Call Summary
- Feb 11th, 2026 10:31 am
Veru (VERU) Q1 2026 Earnings Call Transcript
- Feb 11th, 2026 6:53 am
Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress
- Feb 11th, 2026 4:30 am
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
- Feb 4th, 2026 6:30 am
Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges
- Dec 17th, 2025 12:00 pm
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
- Dec 17th, 2025 4:30 am
Veru to Report Fiscal Year 2025 Financial Results on December 17th
- Dec 10th, 2025 6:30 am
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
- Dec 4th, 2025 6:30 am
Scroll